2019
DOI: 10.1002/1873-3468.13631
|View full text |Cite
|
Sign up to set email alerts
|

Inactivation of the glutathione peroxidase GPx4 by the ferroptosis‐inducing molecule RSL3 requires the adaptor protein 14‐3‐3ε

Abstract: Ras‐selective lethal small molecule 3 (RSL3), a drug candidate prototype for cancer chemotherapy, triggers ferroptosis by inactivating the glutathione peroxidase glutathione peroxidase 4 (GPx4). Here, we report the purification of the protein indispensable for GPx4 inactivation by RSL3. Mass spectrometric analysis identified 14‐3‐3 isoforms as candidates, and recombinant human 14‐3‐3ε confirms the identification. The function of 14‐3‐3ε is redox‐regulated. Moreover, overexpression or silencing of the gene codi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
34
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(41 citation statements)
references
References 40 publications
1
34
1
Order By: Relevance
“…One of the compounds (erastin) inhibited the glutamate/cystine antiporter, which leads to a deprivation of intracellular cysteine and, thus, to loss of GSH. A second one (inhibitor of GPx4 [RSL3]) proved to inhibit GPx4 in situ (195), a phenomenon that has recently been shown to require the participation of the redox-regulated adaptor protein 14-3-3e (185). The cell death caused by these compounds was also not associated with the typical pattern of apoptosis, but was accompanied by massive lipid peroxidation; was inhibited by lipophilic antioxidants, inhibitors of iron uptake and iron chelators (43,196), therefore named ferroptosis (43); and in 2015 classified as an ''iron-dependent form of regulated cell death under the control of glutathione peroxidase 4'' (65).…”
Section: Gpx4mentioning
confidence: 99%
“…One of the compounds (erastin) inhibited the glutamate/cystine antiporter, which leads to a deprivation of intracellular cysteine and, thus, to loss of GSH. A second one (inhibitor of GPx4 [RSL3]) proved to inhibit GPx4 in situ (195), a phenomenon that has recently been shown to require the participation of the redox-regulated adaptor protein 14-3-3e (185). The cell death caused by these compounds was also not associated with the typical pattern of apoptosis, but was accompanied by massive lipid peroxidation; was inhibited by lipophilic antioxidants, inhibitors of iron uptake and iron chelators (43,196), therefore named ferroptosis (43); and in 2015 classified as an ''iron-dependent form of regulated cell death under the control of glutathione peroxidase 4'' (65).…”
Section: Gpx4mentioning
confidence: 99%
“…The second well-studied ferroptosis inducer is RSL3 (RAS-selective lethal 3) that inhibits directly the activity of GPX4. It acts by alkylating the nucleophilic active-site of selenocysteine of GPX4, which interacts with the reduced form of the adaptor protein 14-3-3ε, causing the loss of lipid repair and the accumulation of lethal lipid peroxides and cell death by ferroptosis without affecting GSH and system X C − [10].…”
Section: Introductionmentioning
confidence: 99%
“…Ferroptosis occurs when the AA-OH-PE levels are sufficiently high to surpass the cellular threshold (Kagan et al, 2017). Under physiological conditions, toxic lipid peroxides are reduced to non-toxic lipid alcohols by GPX4 to protect cells against oxidative stress (Kagan et al, 2017;Zhang Z. et al, 2018;Vuckovic et al, 2020). However, substantial accumulation of lipid peroxides cannot be effectively eliminated by GPX4, and the excess lipid peroxide damages membrane integrity, leading to cell rupture and ferroptosis, which has been proven in proteomics studies (Forcina and Dixon, 2019;Fujii et al, 2019).…”
Section: Lipid Peroxidationmentioning
confidence: 97%